ADOB — Adorbs Income Statement

0.000.00%

Last trade - 00:00

HealthcareMicro Cap

Annual income statement for Adorbs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0.012	0.018	0	0	0.297
Cost of Revenue
Gross Profit	0.007	0.012	0	0	0.226
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	0.05	0.041	0.065	0.046	0.637
Operating Profit	-0.038	-0.023	-0.065	-0.046	-0.341
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	-0.038	-0.023	-0.065	-0.046	-0.343
Provision for Income Taxes
Net Income After Taxes	-0.038	-0.023	-0.065	-0.046	-0.343
Net Income Before Extraordinary Items
Net Income	-0.038	-0.023	-0.065	-0.046	-0.343
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-0.038	-0.023	-0.065	-0.046	-0.343
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.002	-0.001	-0.002	-0.002	-0.005
Dividends per Share